Question

I need help preparing Data Analysis and Findings on DaVita Dialysis

Answer 1

Sure I can help you with preparing Data Analysis and Findings on DaVita Dialysis. DaVita Inc. provides kidney dialysis services through a network of 2,664 outpatient dialysis centers in the United States, serving 202,700 patients, and 241 outpatient dialysis centers in other countries. The company primarily treats end-stage renal disease (ESRD), which requires patients to undergo dialysis 3 times per week for the rest of their lives. The company has a 37% market share in the dialysis market. It is organized in Delaware and based in Denver. In 2018, 69% of the company's revenues came from Medicare and other government-based health insurance programs. In 2018, 89.6% of the company's patients were covered by government-based health insurance programs. Commercial payers, which accounted for 31% of revenues in 2018, generate all of the company's profit as they reimburse at a much higher rate than government-based health insurance programs. The company is ranked 188th on the 2019 Fortune 500. The name "DaVita" is derived from the Italian language phrase "Dare Vita", which means "giving life".

DaVita Inc., consolidated revenues of $2.74 billion in the first quarter were about $100 million less compared to the first quarter of 2018. Operating income of $341 million was down from $411 million year-to-year. The company generated revenue of about $17 per treatment — with costs of about $11 per treatment.

As of March 31, the company provided dialysis services to approximately 228,900 patients at 2,932 outpatient dialysis centers, of which 2,689 centers were in the United States and 243 centers were in nine countries outside the United States. During the first quarter, the company opened 27 new dialysis centers, acquired two dialysis centers and closed three dialysis centers in the United States.